Structure-Activity Relationships among α-(N)-Heterocyclic Acyl Thiosemicarbazones and Related Compounds as Inhibitors of Herpes Simplex Virus Type 1-specified Ribonucleoside Diphosphate Reductase

References

1. Averett D. R., Lubbers C., Elion G. B., Spector T. 1983; Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme. Journal of Biological Chemistry 258:9831–9838
   [Google Scholar]
2. Bacchetti S., Evelegh M. J., Muirhead B. 1986; Identification and separation of the two subunits of the herpes simplex virus ribonucleotide reductase. Journal of Virology 57:1177–1181
   [Google Scholar]
3. Brockman R. W., Sidwell R. W., Arnett G., Shaddix S. 1970; Heterocyclic thiosemicarbazones: correlation between structure, inhibition of ribonucleotide reductase, and inhibition of DNA viruses. Proceedings of the Society for Experimental Biology and Medicine 13:609–614
   [Google Scholar]
4. Campbell M. J. M. 1975; Transition metal complexes of thiosemicarbazide and thiosemicarbazones. Coordination Chemistry Reviews 15:279–319
   [Google Scholar]
5. Casero R. A. Jr, Klayman D. L., Childs G. E., Scovill J. P., Desjardins R. E. 1980; Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro. Antimicrobial Agents and Chemotherapy 18:317–322
   [Google Scholar]
6. Cohen E. A., Charron J., Perret J., Langelier Y. 1985; Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of non-identical subunits, HI and H2. Journal of General Virology 66:733–745
   [Google Scholar]
7. Cohen G. H. 1972; Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex virus. Journal of Virology 9:408–418
   [Google Scholar]
8. Cory J. G., Sato A., Lasater L. 1980; Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy. Advances in Enzyme Regulation 19:139–150
   [Google Scholar]
9. Dobek A. S., Klayman D. L., Dickson E. T. Jr, Scovill J. P., Tramont E. C. 1980; Inhibition of clinically significant bacterial organisms in vitro by 2-acetylpyridine thiosemicarbazones. Antimicrobial Agents and Chemotherapy 18:27–36
   [Google Scholar]
10. Dobek A. S., Klayman D. L., Dickson E. T. Jr, Scovill J. P., Oster C. N. 1983; Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1- and 3-acetylisoquinoline and related compounds as inhibitors of clinically significant bacteria in vitro. Arzneimittel-Forschung 33:1583–1591
    [Google Scholar]
11. Dutia B. M. 1983; Ribonucleotide reductase induced by herpes simplex virus has a virus-specified constituent. Journal of General Virology 64:513–521
    [Google Scholar]
12. Frame M. C., Marsden H. S., Dutia B. M. 1985; The ribonucleotide reductase induced by herpes simplex virus type 1 involves minimally a complex of two polypeptides (136K and 38K). Journal of General Virology 66:1581–1587
    [Google Scholar]
13. French F. A., Blanz E. J. Jr, Shaddix S. C., Brockman R. W. 1974; α-(N)-Formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity. Journal of Medicinal Chemistry 17:172–181
    [Google Scholar]
14. Goldstein A. 1964 Biostatistics: An Introductory Text p 156 New York: Macmillan;
    [Google Scholar]
15. Huszar D., Bacchetti S. 1981; Partial purification and characterization of the ribonucleotide reductase induced by herpes simplex virus infection of mammalian cells. Journal of Virology 37:580–588
    [Google Scholar]
16. Huszar D., Bacchetti S. 1983; Is ribonucleotide reductase the transforming function of herpes simplex virus 2?. Nature, London 302:76–79
    [Google Scholar]
17. Huszar D., Beharry S., Bacchetti S. 1983; Herpes simplex virus-induced ribonucleotide reductase: development of antibodies specific for the enzyme. Journal of General Virology 64:1327–1335
    [Google Scholar]
18. Klayman D. L., Bartosevich J. F., Griffin T. S., Mason C. J., Scovill J. P. 1979a; 2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. Journal of Medicinal Chemistry 22:855–862
    [Google Scholar]
19. Klayman D. L., Scovill J. P., Bartosevich J. F., Mason C. J. 1979b; 2-Acetylpyridine thiosemicarbazones. 2. N⁴, N⁴-disubstituted derivatives as potential antimalarial agents. Journal of Medicinal Chemistry 22:1367–1373
    [Google Scholar]
20. Klayman D. L., Scovill J. P., Bartosevich J. F., Mason C. J. 1981; 2-Acetylpyridine thiosemicarbazones. 3. Selenium analogs as potential antimalarial agents. European Journal of Medicinal Chemistry 16:317–320
    [Google Scholar]
21. Klayman D. L., Scovill J. P., Mason C. J., Bartosevich J. F., Bruce J., Lin A. J. 1983; 2-Acetylpyridine thiosemicarbazones. 6. 2-Acetylpyridine and 2-butyrylpyridine thiosemicarbazones as antileukemic agents. Arzneimittel-Forschung 33:909–912
    [Google Scholar]
22. Langelier Y., Buttin G. 1981; Characterization of ribonucleotide reductase induction in BHK-21/C13 Syrian hamster cell line upon infection by herpes simplex virus (HSV). Journal of General Virology 57:21–31
    [Google Scholar]
23. Larsen I. K., Sjöberg B.-M, Thelander L. 1982; Characterization of the active site of ribonucleotide reductase of Escherichia coli, bacteriophage T4 and mammalian cells by inhibition studies with hydroxyurea analogues. European Journal of Biochemistry 125:75–81
    [Google Scholar]
24. Moore E. C., Sartorelli A. C. 1984; Inhibition of ribonucleotide reductase by α-(N)-heterocyclic carboxaldehyde thiosemicarbazones. Pharmacology & Therapeutics 24:439–447
    [Google Scholar]
25. Moore E. C., Zedeck M. S., Agrawal K. C., Sartorelli A. C. 1970; Inhibition of ribonucleoside diphosphate reductase by 1-formylisoquinoline thiosemicarbazone and related compounds. Biochemistry 9:4492–4498
    [Google Scholar]
26. Nutter L. M., Cheng Y.-C. 1984; Nature and properties of mammalian ribonucleoside diphosphate reductase. Pharmacology & Therapeutics 26:191–207
    [Google Scholar]
27. Nutter L. M., Grill S. P., Cheng Y. C. 1985; Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds ?. Biochemical Pharmacology 34:777–780
    [Google Scholar]
28. Preston V. G., Palfreyman J. W., Dutia B. M. 1984; Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase. Journal of General Virology 65:1457–1466
    [Google Scholar]
29. Shipman C. Jr, Smith S. H., Carlson R. H., Drach J. C. 1976; Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures. Antimicrobial Agents and Chemotherapy 9:120–127
    [Google Scholar]
30. Shipman C. Jr, Smith S. H., Drach J. C., Klayman D. L. 1981; Antiviral activity of 2-acetylpyridine thiosemicarbazones against herpes simplex virus. Antimicrobial Agents and Chemotherapy 19:682–685
    [Google Scholar]
31. Shipman C. Jr, Smith, S. H., Drach J. C., Klayman D. L. 1986; Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model. Antiviral Research (in press)
    [Google Scholar]
32. Spector T., Jones T. E. 1985; Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors. Journal of Biological Chemistry 260:8694–8697
    [Google Scholar]
33. Spector T., Averett D. R., Nelson D. J., Lambe C. U., Morrison R. W. Jr St., Clair M. H., Furman P. A. 1985; Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition. Proceedings of the National Academy of Sciences, U.S.A. 82:4254–4257
    [Google Scholar]
34. Thelander L., Graslund A. 1983; Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone. Destruction of the tyrosine free radical of the enzyme in an oxygen-requiring reaction. Journal of Biological Chemistry 258:4063–4066
    [Google Scholar]
35. Thelander L., Reichard P. 1979; Reduction of ribonucleotides. Annual Review of Biochemistry 48:133–158
    [Google Scholar]
36. Turk S. R. 1985; Biochemical basis for the anti-herpes and cytotoxic activities of N⁴-derivatives of 2-acetylpyridine thiosemicarbazone.. Ph.D. thesis, The University of Michigan
    [Google Scholar]
37. Turk S. R., Shipman C. Jr, Drach J. C. 1986; Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone. Biochemical Pharmacology 35:1539–1545
    [Google Scholar]